BEAM:BMV
Beam Therapeutics Inc
MX$ 439.00
arrow_downward
-0.63%(-2.79) 1D
10-р сарын 2, 14:00:00 (GMT-6) · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
MX$ 439.00
High
MX$ 439.00
Low
MX$ 439.00
Mkt. cap
2.53 тэрбум
Avg. vol.
12.00
Volume
49.00
52-wk high
MX$ 663.44
52-wk low
MX$ 384.79
No. of employees
540
Open
MX$ 439.00
High
MX$ 439.00
Low
MX$ 439.00
Mkt. cap
2.53 тэрбум
Avg. vol.
12.00
Volume
49.00
52-wk high
MX$ 663.44
52-wk low
MX$ 384.79
No. of employees
540
News stories
From web sources and news partners
Dealroom
·
6 минутын өмнө
Evernorth clears vote for $1B XRP treasury merger, Nasdaq debut set for October 8
Benzinga
·
39 минутын өмнө
S&P 500 Index Outlook: Top Catalysts for US Stocks This Week
AOL.com
·
9 цагийн өмнө
History Says Stocks Typically Fall After a Fed Hike Cycle Begins -- Then Gain 6.8% Within a Year. Here's My Plan.
24/7 Wall St.
·
10 цагийн өмнө
Why Pay to Own U.S. Stocks? This Zero-Fee ETF Is Beating the S&P 500
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc